The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Acadia Pharmaceuticals announce a partnership to provide free educational materials to patients and their care partners. The resources will focus on cognitive changes and other non-motor symptoms in Parkinson’s.

“‘Will I get dementia?’ ‘What can I do now to prevent it?’ These are just a few of the questions I hear regularly from patients with Parkinson’s and their families.

“This partnership aims to educate the community and to empower people to take action today — whether that’s starting a conversation with family to lessen fear or practicing healthy habits to boost brain health.”

— Rachel Dolhun, MD, MJFF vice president of medical communications and a board-certified movement disorder specialist

Partnership Aims to Foster a Dialogue

Stigma and misperceptions about Parkinson’s disease (PD) and its symptoms can hinder much-needed research into understanding the disease and how to treat and, ultimately, prevent it. The MJFF-Acadia partnership will foster a dialogue around thinking and memory changes and associated neuropsychiatric symptoms in PD in order to connect patients and families to practical and accessible resources.

Through support from Acadia Pharmaceuticals, the Foundation will release a series of resources on cognitive changes — including an “Ask the MD” video, a webinar and a podcast — culminating with the spring 2021 relaunch of MJFF’s guide, “Navigating Cognitive Changes in Parkinson’s Disease” that will include the most recent information on currently available treatments and research.

Funding from Acadia allows the Foundation to maintain editorial oversight in the creation of high-quality educational resources, while directing donor-raised dollars toward critical research, they explain in a media release.

[Source(s): Michael J. Fox Foundation for Parkinson’s Research, Acadia Pharmaceuticals, PR Newswire]

Related Content:
Parkinson’s Podcast Relaunches at Michael J. Fox Foundation
Michael J. Fox Foundation Grants Expand Parkinson’s Disease Research
Ken Griffin Alpha-synuclein Imaging Competition Winners Announced